About the programme
To be eligible, your children must:
- Have a diagnosis of autism spectrum disorder (ASD) or a Rare Genetic Neurodevelopmental Disorder (e.g., Angelman syndrome, Smith-Magenis syndrome, Prader-Willi syndrome)
- Be aged between 2-18 years
- Be experiencing some type of sleep problem (e.g., difficulty falling asleep, unwanted co-sleeping, or frequent night-wakings)
If you’d like to know more about eligibility, contact the Good Nights team below.
When your child has been accepted into the programme, the team work with your family to:
- Understand the nature, type and severity of the sleep problem
- Understand the impact of the sleep problem on the daytime functioning and wellbeing of your child and your family
- Set treatment goals
Before we being treatment, we must assess the type, severity, and characteristics of your child’s sleep problems and why they are occurring.
We do this through:
- Parent-reported sleep diaries
- Video recordings of your child’s sleep (where appropriate and consent is provided)
- Actigraphs (small devices worn on the wrist that record sleep patterns)
- Sleep questionnaires
- Functional Behavioural Assessment (why is the sleep problem occurring?)
After the assessment period, it’s time to formulate a treatment plan for your child.
We appreciate that every child, family, and situation is different. That’s why the Good Nights team work in collaboration with your family to develop an individualised sleep treatment programme specific to your child.
In the treatment phase:
- You will lead the implementation of the treatment plan in your own home
- The team will support and guide you through the treatment until your goals have been met, the sleep problem has been resolved, or you decide to withdraw from the programme
- Your child’s progress will be monitored by the same tools used in the Assessment Period (diaries, actigraphs etc)
- The team work closely with you to make adjustments to the plan as and when they are needed
After the treatment goals have been met, the team will arrange follow-up monitoring to assess whether your child’s progress has been maintained over time.
Typically, the team will assess your child at:
- 4-6 weeks after end of treatment (short-term follow-up)
- 12-14 weeks after end of treatment (long-term follow-up)